ZW10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.941000E-01
Normal-vs-Stage2
8.671400E-01
Normal-vs-Stage3
1.601170E-01
Normal-vs-Stage4
3.613400E-01
Stage1-vs-Stage2
5.329400E-01
Stage1-vs-Stage3
3.888200E-01
Stage1-vs-Stage4
2.602000E-01
Stage2-vs-Stage3
1.305650E-01
Stage2-vs-Stage4
3.276800E-01
Stage3-vs-Stage4
6.739900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.777000E-01
Normal-vs-AfricanAmerican
3.661200E-01
Normal-vs-Asian
9.069400E-01
Caucasian-vs-AfricanAmerican
2.194400E-01
Caucasian-vs-Asian
7.464200E-01
AfricanAmerican-vs-Asian
2.915000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.744200E-01
Normal-vs-Female
8.589400E-01
Male-vs-Female
4.141000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.108800E-01
Normal-vs-Age(41-60Yrs)
5.543200E-01
Normal-vs-Age(61-80Yrs)
8.274200E-01
Normal-vs-Age(81-100Yrs)
7.803800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.029430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.611200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.811200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.955600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.191600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.904200E-01
Normal-vs-Daily Drinker
9.557600E-01
Normal-vs-Weekly Drinker
7.149400E-01
Normal-vs-Occasional Drinker
5.915200E-01
Normal-vs-Social Drinker
9.350000E-01
Non Drinker-vs-Daily Drinker
9.213800E-01
Non Drinker-vs-Weekly Drinker
5.977400E-01
Non Drinker-vs-Occasional Drinker
3.591600E-01
Non Drinker-vs-Social Drinker
8.897000E-01
Daily Drinker-vs-Weekly Drinker
6.977600E-01
Daily Drinker-vs-Occasional Drinker
3.590200E-01
Daily Drinker-vs-Social Drinker
8.286600E-01
Weekly Drinker-vs-Occasional Drinker
1.341560E-01
Weekly Drinker-vs-Social Drinker
4.507200E-01
Occasional Drinker-vs-Social Drinker
3.982400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.588600E-01
Normal-vs-Grade 2
7.835000E-01
Normal-vs-Grade 3
6.778400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.140800E-03
Grade 1-vs-Grade 3
2.623400E-04
Grade 1-vs-Grade 4
9.588600E-01
Grade 2-vs-Grade 3
2.904500E-02
Grade 2-vs-Grade 4
7.835000E-01
Grade 3-vs-Grade 4
6.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.569600E-01
Normal-vs-NonDiabetic
9.694400E-01
Diabetic-vs-NonDiabetic
2.950400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.024800E-01
Normal-vs-NoPancreatitis
9.986400E-01
Pancreatitis-vs-NoPancreatitis
5.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.756600E-01
Normal-vs-N1
8.755000E-01
N0-vs-N1
6.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.098200E-01
Normal-vs-TP53-NonMutant
9.131600E-01
TP53-Mutant-vs-TP53-NonMutant
1.431800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
